Prenetics, a Hong Kong-based biotechnology start-up, is about to become the first home-grown company to sell genetic profiling kits that test for the risk of cancer directly to the consumer.
Until now the four-year-old company, backed by Alibaba Group Holding, Ping An Insurance Group and Lippo Group, has supplied non-clinical genetic test kits to insurers, who then pass them on as gifts to their policyholders.
On Thursday, it will venture into direct sales for the first time via its online...
↧